Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by combining ...